regadenoson
Generic: REGADENOSON·Brand: LEXISCAN, REGADENOSON
regadenoson: sourced relationships with 1 company · 1 FDA decision.
regadenoson evidence translation
What we can confirm
1 FDA record
What it means
Source-backed records connect regadenoson to RDY; that link alone does not prove the drug works.
What to watch
Watch for new trials or company disclosures after the FDA record.
BioSniper AIPage evidence connected
Prepared research question
How could regadenoson → RDY affect its developer, and what evidence supports the link?
Run cited research
Traceable citations · Unknowns marked
Dated Pipeline Records (1)
| Company | Dated record stage |
|---|---|
| DR REDDYS LABORATORIES LTD (RDY) Reported 2022-04-11 · Current development: unknownSource | Approved |
Frequently asked questions
Which companies have sourced relationships with regadenoson?
regadenoson has dated SEC/FDA relationship records for DR REDDYS LABORATORIES LTD.
What is regadenoson's latest FDA decision?
The most recent tracked FDA decision for regadenoson is Approval, dated April 11, 2022.